Gastrointestinal Bleeding Prevention and Management

Risk Factors

• The use of corticosteroids, anticoagulants, and antiplatelet drugs increases the risk of GI bleeding, especially when combined with NSAIDs, in patients with a history of gastrointestinal issues 1
• Helicobacter pylori infection increases the risk of upper GI complications by 2-4 fold, and has surpassed NSAIDs as the most commonly identified risk factor among patients with bleeding ulcers in some studies 1, 2
• Advanced age increases the risk of hemorrhagic gastritis approximately 4% per year, making elderly patients more susceptible 1
• History of previous ulcer disease is the strongest risk factor for GI complications, particularly in patients with a history of bleeding ulcers 2
• Concomitant use of NSAIDs with anticoagulants or other NSAIDs (including low-dose aspirin) dramatically increases risk, particularly in elderly patients 1

Risk Stratification

• Patients can be categorized as low risk if they have an absence of risk factors, moderate risk if they have 1-2 risk factors, high risk if they have multiple risk factors or concomitant use of aspirin, steroids, or anticoagulants, and very high risk if they have a history of prior ulcer complications, as stated by the American Gastroenterological Association 2

Prevention and Management

• H. pylori testing and eradication is recommended for all patients requiring regular NSAID therapy, according to the American Gastroenterological Association 2
• Gastroprotection using proton pump inhibitors (PPIs) is recommended in high-risk patients, particularly those with a history of gastrointestinal bleeding, as stated by the American College of Gastroenterology 1
• Avoidance of medication combinations, particularly NSAIDs with anticoagulants, steroids, or other NSAIDs, is crucial in preventing hemorrhagic gastritis 1
• The American College of Cardiology recommends using the lowest effective dose of naproxen for the shortest duration possible to minimize bleeding risk 3, 4
• Regular monitoring should include skin examination for petechiae or bruising, complete blood count to assess for thrombocytopenia, and coagulation studies if bleeding concerns arise 3, 4
• Consideration of gastroprotection with proton pump inhibitors (PPIs) is recommended in high-risk patients to minimize the risk of petechiae and other bleeding complications 4
• Patients at high risk for bleeding complications who require NSAID therapy might benefit from COX-2 selective inhibitors, though these carry their own cardiovascular risks, according to the American Heart Association 5
• Avoiding concomitant use of naproxen with other NSAIDs, anticoagulants, or antiplatelet drugs when possible is advised to reduce the risk of bleeding complications 1